See the DrugPatentWatch profile for Propranolol
Why are generic versions of propranolol not yet widely available?
As of my knowledge cutoff in 2023, the patent for propranolol, a popular beta-blocker medication, is still valid, which limits the availability of generic versions [1]. Propranolol has been a key medication in treating various cardiovascular and neurological conditions, including high blood pressure, migraines, and anxiety.
When will the exclusivity expire?
According to DrugPatentWatch.com, the patent for propranolol was set to expire in 2025 in the United States, but this may be subject to change [2]. As a result, generic versions of the medication may become available shortly after the patent expires.
What are the current market costs for propranolol?
The current market cost of propranolol can vary significantly depending on the country, dosage form, and manufacturer. According to GoodRx, a popular online pharmacy pricing platform, a 30-day supply of propranolol can cost anywhere from $10 to over $200 USD, depending on the specific formulation and strength [3].
Comparison of generic alternatives
Although propranolol is not yet widely available as a generic, some generic versions of beta-blocker medications have entered the market. However, these alternatives may have differences in terms of dosage, formulation, or efficacy compared to propranolol.
How does the cost of propranolol compare to other beta-blocker options?
Other beta-blocker medications, such as nadolol or timolol, may be available as generics and have similar efficacy profiles to propranolol. However, the cost of these alternatives can vary depending on the specific formulation and manufacturer.
Regulatory landscape and biosimilar entrants
As the patent for propranolol approaches its expiration date, regulatory agencies like the FDA will evaluate biosimilar applications for the medication. This may lead to increased competition and more affordable options for patients in the future.
Patient concerns and access barriers
The limited generic availability of propranolol and the associated costs can pose challenges for patients who rely on this medication to manage their conditions. As the regulatory landscape evolves, patients can expect to have more affordable options in the future.
Sources:
[1] DrugPatentWatch.com - Propranolol [https://www.drugpatentwatch.com/drug/pfizer-propranolol]
[2] DrugPatentWatch.com - Patent Expiration Dates for Propranolol [https://www.drugpatentwatch.com/expiry/propranolol]
[3] GoodRx - Propranolol Prices [https://www.goodrx.com/propranolol/price]
[4] FDA - Propranolol [https://www.fda.gov/drugs/atfaqs/propranolol]